Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...
The Healthy on MSN1d
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...
But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...
Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...
Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
When I lost weight on WW, I devoted all of my time to the program and I was successful. It was when life got hard that the ...
Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback